Hospital De La Serena - Emergency Unit
La Serena, Coquimbo Region, IV Region, Chile
NCT Number: NCT00528138
It has recently been published that hyperbilirubinemia is a reliable marker for the preoperative diagnosis of perforated acute appendicitis.
The investigators believe, based on their own previous publications, that C-reactive protein (CRP) with or without a white blood cell count and some other clinical parameters, are more specific markers for the preoperative diagnosis of perforated acute appendicitis.
The purpose of this study is to prospectively compare the specificity and sensitivity of hyperbilirubinemia CRP, white blood cell count and other clinical parameters for the preoperative diagnosis of acute appendicitis.
Looking for future studies?
Notify Me15 year and older
All sexes
Observational
La Serena, Coquimbo Region, IV Region, Chile
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
CRP, white blood cell count, hepatic function tests
Cirujanos la Serena
Other
Prospective Study Comparing Hyperbilirubinemia, CRP, White Blood Cell Count, and Other Clinical Parameters for the Preoperative Diagnosis of Perforated Acute Appendicitis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03289351
Appendicitis, Cecal Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT03159754
Appendicitis, Cecal Diseases
Ann Arbor, Michigan, United States
View Trial DetailsNCT04512196
Appendicitis, Cecal Diseases
Kota Kinabalu, Sabah, Malaysia
View Trial DetailsNCT02724410
Appendicitis, Cecal Diseases
View Trial Details